Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10072-021-05216-z.pdf
Reference27 articles.
1. Klotz L, Havla J, Schwab N et al (2019) Risks and risk management in modern multiple sclerosis immunotherapeutic treatment. Ther Adv Neurol Disord 12:1756286419836571. https://doi.org/10.1177/1756286419836571
2. Lebrun C, Rocher F (2018) Cancer risk in patients with multiple sclerosis: potential impact of disease-modifying drugs. CNS Drugs 32(10):939–949. https://doi.org/10.1007/s40263-018-0564-y
3. Melamed E, Lee MW (2020) Multiple sclerosis and cancer: the ying-yang effect of disease modifying therapies. Front Immunol 10:2954–2954. https://doi.org/10.3389/fimmu.2019.02954
4. Giovannoni G (2018) Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigm. Curr Opin Neurol 31(3):233–243. https://doi.org/10.1097/wco.0000000000000561
5. D'Amico E, Leone C, Graziano G et al (2016) The use of immunosuppressant therapy for multiple sclerosis in Italy: a multicenter retrospective study. PLoS One 11(6):e0157721. https://doi.org/10.1371/journal.pone.0157721
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-inflammatory Therapy for Sarcoidosis;Clinics in Chest Medicine;2024-03
2. Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study;Multiple Sclerosis and Related Disorders;2023-12
3. Enhanced electrochemical performance of in-situ synthesized Cu nanoparticle/C spheres composite for highly sensitive sensing of azathioprine immunosuppressive drug;Composites Part B: Engineering;2022-08
4. Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression;Journal of Neurology;2022-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3